These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 36510194)

  • 1. Harnessing bioactive nanomaterials in modulating tumor glycolysis-associated metabolism.
    Gu Z; Yu C
    J Nanobiotechnology; 2022 Dec; 20(1):528. PubMed ID: 36510194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy.
    Cheng Q; Shi XL; Li QL; Wang L; Wang Z
    Adv Sci (Weinh); 2024 Jan; 11(3):e2305662. PubMed ID: 37941489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy.
    Guo L; Yang J; Wang H; Yi Y
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy.
    Chen Z; Yue Z; Yang K; Shen C; Cheng Z; Zhou X; Li S
    Adv Healthc Mater; 2023 Oct; 12(26):e2300882. PubMed ID: 37539730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid Nanomaterials for Cancer Immunotherapy.
    Li J; Lu W; Yang Y; Xiang R; Ling Y; Yu C; Zhou Y
    Adv Sci (Weinh); 2023 Feb; 10(6):e2204932. PubMed ID: 36567305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current applications and future prospects of nanomaterials in tumor therapy.
    Huang Y; Fan CQ; Dong H; Wang SM; Yang XC; Yang SM
    Int J Nanomedicine; 2017; 12():1815-1825. PubMed ID: 28331307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-based Nanomaterials in the Immunotherapy.
    Huang H; Gao S; Cai X
    Curr Drug Metab; 2023; 24(5):367-384. PubMed ID: 37069706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating Glycolysis to Improve Cancer Therapy.
    Chelakkot C; Chelakkot VS; Shin Y; Song K
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Nanodelivery Systems Based on Metabolism Reprogramming Strategies for Enhanced Tumor Therapy.
    Zhang Z; Liang X; Yang X; Liu Y; Zhou X; Li C
    ACS Appl Mater Interfaces; 2024 Feb; 16(6):6689-6708. PubMed ID: 38302434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment.
    Jiang Z; Liu Z; Li M; Chen C; Wang X
    EBioMedicine; 2019 Apr; 42():431-442. PubMed ID: 30935888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterials as Smart Immunomodulator Delivery System for Enhanced Cancer Therapy.
    Yuan C; Liu Y; Wang T; Sun M; Chen X
    ACS Biomater Sci Eng; 2020 Sep; 6(9):4774-4798. PubMed ID: 33455212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulating Nanomedicine for Cancer Therapy.
    Liu Z; Jiang W; Nam J; Moon JJ; Kim BYS
    Nano Lett; 2018 Nov; 18(11):6655-6659. PubMed ID: 30185039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery.
    Talekar M; Boreddy SR; Singh A; Amiji M
    Expert Opin Biol Ther; 2014 Aug; 14(8):1145-59. PubMed ID: 24762115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered nanomaterials for synergistic photo-immunotherapy.
    Guo R; Wang S; Zhao L; Zong Q; Li T; Ling G; Zhang P
    Biomaterials; 2022 Mar; 282():121425. PubMed ID: 35217344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design Strategies of Tumor-Targeted Delivery Systems Based on 2D Nanomaterials.
    Ding L; Liang M; Li C; Ji X; Zhang J; Xie W; Reis RL; Li FR; Gu S; Wang Y
    Small Methods; 2022 Nov; 6(11):e2200853. PubMed ID: 36161304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting glycolysis for cancer therapy using drug delivery systems.
    Huang Y
    J Control Release; 2023 Jan; 353():650-662. PubMed ID: 36493949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomembrane nanostructures: Multifunctional platform to enhance tumor chemoimmunotherapy via effective drug delivery.
    Jiang X; Wu L; Zhang M; Zhang T; Chen C; Wu Y; Yin C; Gao J
    J Control Release; 2023 Sep; 361():510-533. PubMed ID: 37567505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomaterials-Induced Redox Imbalance: Challenged and Opportunities for Nanomaterials in Cancer Therapy.
    Wu X; Zhou Z; Li K; Liu S
    Adv Sci (Weinh); 2024 Apr; 11(16):e2308632. PubMed ID: 38380505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoskeleton-modulating nanomaterials and their therapeutic potentials.
    Park J; Wu Y; Suk Kim J; Byun J; Lee J; Oh YK
    Adv Drug Deliv Rev; 2024 Aug; 211():115362. PubMed ID: 38906478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advancements in two-dimensional nanomaterials for drug delivery.
    Mei X; Hu T; Wang Y; Weng X; Liang R; Wei M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1596. PubMed ID: 31650709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.